Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT)
Blaise, D.; Guyotat, D.; Reiffers, J.; Olive, D.; Michallet, M.; Bellanger, C.; Vernant, J.P.; Ifrah, N.; Attal, M.; Vilmer, E.
Bone Marrow Transplantation 7 Suppl. 2: 150
1991
ISSN/ISBN: 0268-3369 PMID: 1878689 Document Number: 375893
Document emailed within 1 workday
Related Documents
Hassan, H.T.; Krog, C.; Stockschläder, M.; Schleimer, B.; Zeller, W.; Krüger, W.; Erttmann, R.; Zander, A.R. 1997: Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience Anticancer Research 17(1b): 589-599Bursztyn, M.; Zelig, O.; Or, R.; Nagler, A. 1997: Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study Transplantation 63(7): 1034-1036
Merino, A.; Urbano-Ispizua, A.; Marín, P.; Besson, I.; Carreras, E.; Sierra, J.; Salgado, C.; Rovira, M.; Grañena, A.; Montserrat, E. 1993: Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation Sangre 38(5): 359-364
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Michallet, M.; Corront, B.; Hollard, D.; Gratwohl, A.; Domingo, A.; Burnett, S. 1988: Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (8 cases) Nouvelle Revue Francaise d'Hematologie 30(5-6): 467-470
de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Locasciulli, A.; Alberti, A.; de Bock, R.; Cordonnier, C.; Einsele, H.; Engelhard, D.; Grundy, J.; Reusser, P.; Ribaud, P.; Ljungman, P. 1994: Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party Bone Marrow Transplantation 14(5): 833-837
Taaning, E.; Jacobsen, N. 1994: Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation Transplantation Proceedings 26(3): 1826
De Witte, T.; Zwaan, F.; Hermans, J.; Vernant, J.; Kolb, H.; Vossen, J.; Lönnqvist, B.; Beelen, D.; Ferrant, A.; Gmür, J. 1989: Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Bone Marrow Transplantation 4(Suppl 3): 38-39
Li, V.; Molina, L.; Michallet, M.; Hostein, J. 1992: Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion Gastroenterologie Clinique et Biologique 16(1): 29-36
Jeannet, M.; Vaucher, A.; Gervasoni, C. 1972: Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation Schweizerische Medizinische Wochenschrift 102(44): 1598-1600
Marmont, A.M. 1979: Transplantation haemopoiesis. Morphological bone marrow studies after allogeneic marrow transplantation in man for severe aplastic anaemia and acute leukaemia Nouvelle Revue Francaise d'Hematologie 21(2): 133-148
Huang, X.; Guo, N.; Ren, H.; Zhang, Y.; Gao, Z.; Lu, D. 2003: An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation Chinese Medical Journal 116(5): 736-741
Gluckman, E.; Andersen, E.; Lepage, V.; Dausset, J. 1977: Non-HLA lymphocytotoxic antibodies during GVHD after bone marrow transplantation (BMT) Transplantation Proceedings 9(1): 761-763
Cooper, M.H.; Markus, P.M.; Cai, X.; Starzl, T.E.; Fung, J.J. 1991: Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506 Transplantation Proceedings 23(6): 3238-3239
del Rosario Uriarte, M.; Bonomi, R.; Azambuja, C.; Seuánez, H.N. 1997: Bone marrow reconstitution with normal autologous cells demonstrated by VNTR analysis after allogeneic bone marrow transplantation for chronic myelogenous leukemia Leukemia 11(12): 2213-2214
Davies, S.M.; Weisdorf, D.J.; Haake, R.J.; Kersey, J.H.; McGlave, P.B.; Ramsay, N.K.; Blazar, B.R. 1994: Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation Bone Marrow Transplantation 14(1): 73-77
Rosti, G.; Zaccaria, A.; Testoni, N.; Celso, B.; Miggiano, C.; Tura, S.; Sessarego, M.; Marmont, A.M.; Gualandi, F.; Francesco, F. 1991: Cytogenetic follow-up after allogeneic bone marrow transplantation for Ph+ CML: update of the European Cooperative Study Bone Marrow Transplantation 7 Suppl. 2: 19
Bengtsson, M.; Tötterman, T.H.; Smedmyr, B.; Festin, R.; Oberg, G.; Simonsson, B. 1989: Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis Leukemia 3(1): 68-75
Belanger, C.; Esperou-Bourdeau, H.; Raffoux, C.; Gluckman, E. 1991: Unrelated bone marrow transplant. use of IL2 receptor monoclonal antibody (IL2-R-Ab) in prophylaxis of GVHD. the GEGMO Group Bone Marrow Transplantation 7(Suppl 2): 122